Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Assets Average came in at $1.0 billion in Q2 2026, down 19.86% on a YoY basis from $1.3 billion in Q2 2025, and down 6.02% quarter-over-quarter from $1.1 billion in Q1 2026.
Analysis
Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Assets Average for 6 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average fell 19.86% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $1.0 billion (down 19.86% YoY), and the FY2025 full-year result was $1.2 billion, down 17.93% from the prior year.
- Assets Average eased to $1.0 billion in Q2 2026 per DNA's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Assets Average topped out at $2.5 billion in Q1 2023 and bottomed at $1.0 billion in Q2 2026.
- Historically, Assets Average has averaged $1.7 billion across 5 years, with a median of $1.6 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average soared 71.8% in 2022, then plunged 34.49% in 2024.
- Over 5 years, Assets Average stood at $2.2 billion in 2022, then slipped by 16.29% to $1.8 billion in 2023, then retreated by 22.57% to $1.4 billion in 2024, then declined by 19.22% to $1.2 billion in 2025, then fell by 12.38% to $1.0 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $1.0 billion, $1.1 billion, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 29.78 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 2.09 Bn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 7.63 Bn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 16.36 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 2.70 Bn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 1.87 Bn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 1.01 Bn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 27.72 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 16.08 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 5.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.15 Bn |
| Sep 30, 2025 | 1.21 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.34 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | 1.60 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 1.85 Bn |
| Sep 30, 2023 | 2.16 Bn |
| Jun 30, 2023 | 2.35 Bn |
| Mar 31, 2023 | 2.48 Bn |
| Dec 31, 2022 | 2.21 Bn |
| Sep 30, 2022 | 1.93 Bn |
| Jun 30, 2022 | 2.03 Bn |
| Mar 31, 2022 | 2.06 Bn |
| Dec 31, 2021 | 2.11 Bn |
| Sep 30, 2021 | 1.94 Bn |